Yaling Hu

2.2k total citations
38 papers, 1.7k citations indexed

About

Yaling Hu is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Yaling Hu has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Neurology. Recurrent topics in Yaling Hu's work include MicroRNA in disease regulation (10 papers), RNA modifications and cancer (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Yaling Hu is often cited by papers focused on MicroRNA in disease regulation (10 papers), RNA modifications and cancer (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Yaling Hu collaborates with scholars based in China, Canada and United States. Yaling Hu's co-authors include Zhaohui Huang, Zehua Bian, Yuan Yin, Jiwei Zhang, Leyuan Zhou, Yuyang Feng, Bojian Fei, Dong Hua, Zhihua Gao and Chao Quan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Yaling Hu

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaling Hu China 16 1.0k 814 256 211 205 38 1.7k
Zhi-qing Zhang China 28 1.1k 1.1× 483 0.6× 140 0.5× 69 0.3× 208 1.0× 47 1.8k
Bangbao Tao China 21 786 0.8× 506 0.6× 241 0.9× 93 0.4× 181 0.9× 40 1.5k
Soo-Kyung Bae South Korea 7 810 0.8× 275 0.3× 138 0.5× 85 0.4× 247 1.2× 11 1.4k
Song Han China 20 501 0.5× 258 0.3× 139 0.5× 219 1.0× 104 0.5× 64 1.1k
Ningbo Xu China 20 642 0.6× 391 0.5× 100 0.4× 186 0.9× 74 0.4× 33 1.1k
Nunzio Vicario Italy 27 887 0.9× 267 0.3× 191 0.7× 176 0.8× 161 0.8× 70 1.8k
Haifeng Jin China 27 1.2k 1.2× 716 0.9× 93 0.4× 154 0.7× 236 1.2× 48 1.8k
Lixuan Yang China 18 956 1.0× 549 0.7× 118 0.5× 174 0.8× 104 0.5× 42 1.4k
Keirnan Willett United States 13 1.2k 1.2× 232 0.3× 187 0.7× 151 0.7× 76 0.4× 22 2.2k
Elisabetta Mantuano United States 21 561 0.6× 341 0.4× 193 0.8× 114 0.5× 110 0.5× 40 1.3k

Countries citing papers authored by Yaling Hu

Since Specialization
Citations

This map shows the geographic impact of Yaling Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaling Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaling Hu more than expected).

Fields of papers citing papers by Yaling Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaling Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaling Hu. The network helps show where Yaling Hu may publish in the future.

Co-authorship network of co-authors of Yaling Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaling Hu. A scholar is included among the top collaborators of Yaling Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaling Hu. Yaling Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ji, Yu Zhou, Yaling Hu, et al.. (2025). Spatial transcriptomics and multi-omics reveal relapse and resistance mechanisms of EndMT-derived CAFs mediated by TNC and FLNC in glioblastoma. Journal of Translational Medicine. 23(1). 702–702. 3 indexed citations
2.
Liu, Wenyuan, Sufen Li, Jinjing Wang, et al.. (2024). Astragaloside IV alleviates renal fibrosis by inhibiting renal tubular epithelial cell pyroptosis induced by urotensin II through regulating the cAMP/PKA signaling pathway. PLoS ONE. 19(5). e0304365–e0304365. 5 indexed citations
3.
Gong, Lingli, W. F. Mader, Zhening Pu, et al.. (2024). Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53. Advanced Science. 12(4). e2402258–e2402258. 3 indexed citations
4.
Zhang, Mingyu, et al.. (2023). Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis. DNA and Cell Biology. 42(10). 594–607. 12 indexed citations
5.
Fang, Jingai, et al.. (2022). Study on the Mechanism of Radix Astragali against Renal Aging Based on Network Pharmacology. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 5 indexed citations
6.
Fang, Jingai, et al.. (2022). [Effects of astragaloside IV on delaying kidney aging and its mechanisms].. PubMed. 38(5). 448–452. 2 indexed citations
7.
Chen, Lunhao, Yaling Hu, Siyuan Wang, et al.. (2022). mTOR–neuropeptide Y signaling sensitizes nociceptors to drive neuropathic pain. JCI Insight. 7(22). 23 indexed citations
8.
Hu, Yaling, Kelei Cao, Fang Wang, et al.. (2022). Dual roles of hexokinase 2 in shaping microglial function by gating glycolytic flux and mitochondrial activity. Nature Metabolism. 4(12). 1756–1774. 91 indexed citations
9.
Cao, Kelei, Yaling Hu, & Zhihua Gao. (2022). Sense to Tune: Engaging Microglia with Dynamic Neuronal Activity. Neuroscience Bulletin. 39(3). 553–556. 4 indexed citations
10.
Hu, Yaling, Zhenghao Zhang, Jingjing Wang, et al.. (2021). Oncogenic Activity of Glucocorticoid Receptor β Is Controlled by Ubiquitination-Dependent Interaction with USP49 in Glioblastoma Cells. Molecular Cancer Research. 20(1). 92–101. 9 indexed citations
11.
Hu, Yaling, et al.. (2021). Bioinformatics analysis of genes related to iron death in diabetic nephropathy through network and pathway levels based approaches. PLoS ONE. 16(11). e0259436–e0259436. 31 indexed citations
12.
Zhang, Bo, Zaiwang Li, Rui Zhang, et al.. (2019). PKCγ promotes axonal remodeling in the cortico-spinal tract via GSK3β/β-catenin signaling after traumatic brain injury. Scientific Reports. 9(1). 17078–17078. 10 indexed citations
13.
Yin, Yuan, Surui Yao, Yaling Hu, et al.. (2017). The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Clinical Cancer Research. 23(23). 7375–7387. 208 indexed citations
14.
Hu, Yaling, Yuan Yin, Yuyang Feng, et al.. (2016). Glucose deprivation induces chemoresistance in colorectal cancer cells by increasing ATF4 expression. World Journal of Gastroenterology. 22(27). 6235–6235. 18 indexed citations
15.
Bian, Zehua, Liugen Jin, Jiwei Zhang, et al.. (2016). LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Scientific Reports. 6(1). 23892–23892. 313 indexed citations
16.
Yin, Yuan, Mingxu Song, Bing Gu, et al.. (2015). Systematic analysis of key miRNAs and related signaling pathways in colorectal tumorigenesis. Gene. 578(2). 177–184. 32 indexed citations
17.
Yin, Yuan, Bin-Bin Zhang, Weili Wang, et al.. (2014). miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A. Clinical Cancer Research. 20(23). 6187–6199. 169 indexed citations
18.
Zhang, Bin-Bin, Yuan Yin, Yaling Hu, et al.. (2014). MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A. Medical Oncology. 32(1). 331–331. 86 indexed citations
19.
Song, Mingxu, Yuan Yin, Jiwei Zhang, et al.. (2014). MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Protein & Cell. 5(11). 851–861. 76 indexed citations
20.
Hu, Yaling, et al.. (2010). Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells. Biochemical and Biophysical Research Communications. 392(3). 329–334. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026